GOA26 shows 61.3% lower blood alcohol concentration in porcine study
AI Summary- GOA Therapeutics presented GOA26 preclinical findings at the 85th AAST annual meeting.
- 61.3% lower BAC was recorded in treated animals 20 minutes after administration.
- GOA plans to submit an IND application by end-2026 and begin trials in 2027.